These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32483396)

  • 1. Effect of preoperative cancer treatment on epidermal growth factor receptor (EGFR) receptor expression level in ABY-029 guided sarcoma surgery.
    Xu X; Samkoe KS; Henderson ER
    Proc SPIE Int Soc Opt Eng; 2020 Feb; 11222():. PubMed ID: 32483396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant Therapies Do Not Reduce Epidermal Growth Factor Receptor (EGFR) Expression or EGFR-Targeted Fluorescence in a Murine Model of Soft-Tissue Sarcomas.
    Streeter SS; Xu X; Hebert KA; Werth PM; Hoopes PJ; Jarvis LA; Pogue BW; Paulsen KD; Samkoe KS; Henderson ER
    Mol Imaging Biol; 2024 Apr; 26(2):272-283. PubMed ID: 38151580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor-targeted fluorescence is unaffected by standard neoadjuvant therapies in human sarcomas.
    Henderson ER; Werth P; Xu X; Jarvis LA; Paulsen KD; Hoopes PJ; Rosenthal EL; Pogue BW; Samkoe KS
    Proc SPIE Int Soc Opt Eng; 2022; 119430():. PubMed ID: 36052271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical imaging of epidermal growth factor receptor with ABY-029 in soft-tissue sarcoma for fluorescence-guided surgery and tumor detection.
    Samkoe KS; Sardar HS; Bates BD; Tselepidakis NN; Gunn JR; Hoffer-Hawlik KA; Feldwisch J; Pogue BW; Paulsen KD; Henderson ER
    J Surg Oncol; 2019 Jun; 119(8):1077-1086. PubMed ID: 30950072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicity and Pharmacokinetic Profile for Single-Dose Injection of ABY-029: a Fluorescent Anti-EGFR Synthetic Affibody Molecule for Human Use.
    Samkoe KS; Gunn JR; Marra K; Hull SM; Moodie KL; Feldwisch J; Strong TV; Draney DR; Hoopes PJ; Roberts DW; Paulsen K; Pogue BW
    Mol Imaging Biol; 2017 Aug; 19(4):512-521. PubMed ID: 27909986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of Fluorescence-Guided Surgery to Subsurface Cancers Requiring Wide Local Excision: Literature Review and Novel Developments Toward Indirect Visualization.
    Samkoe KS; Bates BD; Elliott JT; LaRochelle E; Gunn JR; Marra K; Feldwisch J; Ramkumar DB; Bauer DF; Paulsen KD; Pogue BW; Henderson ER
    Cancer Control; 2018; 25(1):1073274817752332. PubMed ID: 29334791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved Discrimination of Tumors with Low and Heterogeneous EGFR Expression in Fluorescence-Guided Surgery Through Paired-Agent Protocols.
    Wang C; Xu X; Folaron M; Gunn JR; Hodge S; Chen EY; Hoopes PJ; Tichauer KM; Samkoe KS
    Mol Imaging Biol; 2023 Feb; 25(1):110-121. PubMed ID: 34651290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a Suitable Untargeted Agent for the Clinical Translation of ABY-029 Paired-Agent Imaging in Fluorescence-Guided Surgery.
    Wang C; Xu X; Hodge S; Chen EY; Hoopes PJ; Tichauer KM; Samkoe KS
    Mol Imaging Biol; 2023 Feb; 25(1):97-109. PubMed ID: 34642897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-agent fluorescent labeling of soft-tissue sarcomas improves the contrast based upon targeting both interstitial and cellular components of the tumor milieu.
    Sardar HS; Zai Q; Xu X; Gunn JR; Pogue BW; Paulsen KD; Henderson ER; Samkoe KS
    J Surg Oncol; 2020 Dec; 122(8):1711-1720. PubMed ID: 32885452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescent Affibody Molecule Administered In Vivo at a Microdose Level Labels EGFR Expressing Glioma Tumor Regions.
    de Souza AL; Marra K; Gunn J; Samkoe KS; Hoopes PJ; Feldwisch J; Paulsen KD; Pogue BW
    Mol Imaging Biol; 2017 Feb; 19(1):41-48. PubMed ID: 27379987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and evaluation of a connective tissue phantom model for subsurface visualization of cancers requiring wide local excision.
    Samkoe KS; Bates BD; Tselepidakis NN; DSouza AV; Gunn JR; Ramkumar DB; Paulsen KD; Pogue BW; Henderson ER
    J Biomed Opt; 2017 Dec; 22(12):1-12. PubMed ID: 29274143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring microdose ABY-029 fluorescence signal in a primary human soft-tissue sarcoma resection.
    Samkoe KS; Sardar HS; Gunn J; Feldwisch J; Linos K; Henderson E; Pogue B; Paulsen K
    Proc SPIE Int Soc Opt Eng; 2019 Feb; 10862():. PubMed ID: 31595101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical Evaluation of Candidate Biomarkers for Fluorescence-Guided Surgery of Myxofibrosarcoma Using an Objective Scoring Method.
    Rijs Z; Belt E; Kalisvaart GM; Sier CFM; Kuppen PJK; Cleven AHG; Vahrmeijer AL; van de Sande MAJ; van Driel PBAA
    Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspectives on the Phase 0 clinical trial of microdose administration of ABY-029 for fluorescence guided surgery: Stability testing.
    Samkoe KS; Hull S; Elliott J; Sardar HS; Gunn J; Linos K; Tafe L; Harris B; Feldwisch J; Pogue BW; Roberts D; Henderson E; Paydarfar J; Paulsen K
    Proc SPIE Int Soc Opt Eng; 2020 Feb; 11222():. PubMed ID: 36051445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting tumors with a killer-reporter adenovirus for curative fluorescence-guided surgery of soft-tissue sarcoma.
    Yano S; Miwa S; Kishimoto H; Uehara F; Tazawa H; Toneri M; Hiroshima Y; Yamamoto M; Urata Y; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM
    Oncotarget; 2015 May; 6(15):13133-48. PubMed ID: 26033451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of cetuximab alone and in combination with radiation and/or chemotherapy in lung cancer.
    Raben D; Helfrich B; Chan DC; Ciardiello F; Zhao L; Franklin W; Barón AE; Zeng C; Johnson TK; Bunn PA
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):795-805. PubMed ID: 15701870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is High-dose Radiation Therapy Associated With Early Revision Due to Aseptic Loosening in Patients With a Sarcoma of the Lower Extremities Reconstructed With a Cemented Endoprosthesis?
    Arnold MT; Geiger EJ; Hart C; Greig D; Trikha R; Sekimura T; Eckardt JJ; Bernthal NM
    Clin Orthop Relat Res; 2023 Mar; 481(3):475-487. PubMed ID: 35977001
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.